BioStock: Congress in Poland paves the way for Sensidose

Recently, Sensidose participated in the Polish Neurology Society’s annual science and education conference in Lublin. An increased presence is a strategic step ahead of the planned market launch of the company’s drug Flexilev for the treatment of Parkinson’s disease in Poland. The company’s CEO Jack Spira tells us more about the launch plans in Poland and the learnings from the congress.

Read the whole article about Sensidose at biostock.se:

https://www.biostock.se/en/2022/09/congress-in-poland-paves-the-way-for-sensidose/

Detta är ett pressmeddelande från BioStock – Connecting Innovation & Capital. https://www.biostock.se